glucagon has been researched along with Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flint, A; Ingwersen, SH; Jacobsen, LV; Olsen, AK | 1 |
| Deacon, CF; Gaeckler, D; Gallwitz, B; Holst, JJ; Kranz, D; Meier, JJ; Nauck, MA; Schmidt, WE | 1 |
| Nair, KS; Tom, A | 1 |
2 review(s) available for glucagon and Kidney Failure
| Article | Year |
|---|---|
Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics.
Topics: Area Under Curve; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Interactions; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Lipids; Liraglutide; Liver Failure; Renal Insufficiency; Sex Factors | 2016 |
Assessment of branched-chain amino Acid status and potential for biomarkers.
Topics: Aging; Amino Acids, Branched-Chain; Biomarkers; Fasting; Glucagon; Hepatic Insufficiency; Humans; Insulin; Proteins; Renal Insufficiency; Stress, Physiological | 2006 |
1 other study(ies) available for glucagon and Kidney Failure
| Article | Year |
|---|---|
Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
Topics: Analysis of Variance; Creatinine; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Kinetics; Male; Middle Aged; Patient Selection; Peptide Fragments; Protein Precursors; Reference Values; Renal Insufficiency | 2004 |